Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Net Cash Flow (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Net Cash Flow for 12 consecutive years, with -$6.5 million as the latest value for Q1 2026.

  • For Q1 2026, Net Cash Flow rose 79.85% year-over-year to -$6.5 million; the TTM value through Mar 2026 reached -$61.7 million, down 179.87%, while the annual FY2025 figure was -$87.4 million, 164.3% down from the prior year.
  • Net Cash Flow hit -$6.5 million in Q1 2026 for Cartesian Therapeutics, up from -$18.3 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $132.0 million in Q3 2024 and bottomed at -$34.0 million in Q3 2023.
  • Average Net Cash Flow over 5 years is $291529.4, with a median of -$6.6 million recorded in 2024.
  • On a YoY basis, Net Cash Flow climbed as much as 7416.87% in 2022 and fell as far as 992.78% in 2022.
  • Cartesian Therapeutics' Net Cash Flow stood at -$6.4 million in 2022, then skyrocketed by 57.42% to -$2.7 million in 2023, then plummeted by 142.73% to -$6.6 million in 2024, then plummeted by 177.74% to -$18.3 million in 2025, then soared by 64.44% to -$6.5 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$6.5 million, -$18.3 million, and -$16.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.